Answers are grounded in this paper and cite their sources.
In addition to its established role in bone and mineral homeostasis, there is growing evidence for a role of vitamin D in skeletal muscle physiology. Vitamin D deficiency has long been implicated in muscle function. Observational studies report an increase in muscle weakness and falls in vitamin D deficiency. Clinical trials also suggest that vitamin D supplementation may improve muscle strength and balance and reduce risk of falls in those with vitamin D deficiency; however, there is controversy regarding these effects because the current evidence base is restricted by highly heterogeneous studies (1). Vitamin D deficiency may be associated with preferential atrophy of type II muscle fibers, and this potentially explains the association of vitamin D with reduced strength and increased risk of falls. However, vitamin D-associated improvements in skeletal muscle function are unlikely to be explained by muscle hypertrophy alone. For example, we have previously reported that spanning almost 3 years in a population-based study of older adults, higher baseline serum 25-hydroxyvitamin D (25OHD) was associated with improved maintenance of lower-limb strength but not appendicular lean mass assessed by dual-energy x-ray absorptiometry (2). If vitamin D exerts a direct effect on human skeletal muscle, it follows that vitamin D receptors (VDRs) should be located in the skeletal muscle. Research has indicated that 1,25-dihydroxyvitamin D3 (1,25OH2D3) binds to a nuclear receptor in muscle and promotes de novo protein synthesis, and in support of this, VDR-knockout mice exhibit reduced muscle fiber size and poor vestibular function. Studies using several different antibodies have reported that the VDR is expressed in adult muscle tissue, but this is currently controversial; the VDR was reported to be undetectable in normal and mature mouse, rat, and human skeletal muscle tissue using a highly sensitive and specific VDR antibody (3). The present questions surrounding the VDR are whether the VDR is indeed expressed in skeletal muscle in vivo and whether it exists in fully differentiated adult muscle or only in immature muscle cells as suggested by in vitro studies (1). A recent Endocrine Society Scientific Statement has concluded that there is controversy regarding the role of vitamin D in skeletal muscle function but that there is evidence that effects of vitamin D on muscle function may be both direct and indirect. The statement suggests that the effects of vitamin D on muscle function may be explained by vitamin D-related changes in calcium absorption, as reported by Ebeling et al (4), rather than a direct interaction with skeletal muscle VDR (3). We propose there may be an additional mechanism through which vitamin D exerts an indirect effect, which may be unrelated to a skeletal muscle VDR; reductions in intra- and intermuscular adipose tissue (IMAT) deposition. A characteristic of aging skeletal muscle is increased deposition of adipose tissue within and between muscle fibers, and IMAT appears to have independent and deleterious outcomes for skeletal muscle function. It has been proposed that IMAT may contribute to declines in muscle function by altering the orientation and hence force production capabilities of skeletal muscle and by secreting inflammatory cytokines leading to systemic low-level inflammation that has been associated with reduced force production (5). Observational studies have reported an association between IMAT and functional decline in older adults. Among well-functioning participants of the U.S. Health, Aging and Body Composition study, IMAT at the midthigh was assessed using computed tomography (CT). Mean attenuation of the muscle was determined, with lower attenuation scores indicating higher degrees of fat infiltration. Men and women in the lowest quartile for muscle attenuation had relative risks of 1.9 and 1.7 for self-reported mobility limitations 2.5 years later, compared with those in the highest quartile (6). A cross-sectional study by Marcus et al (5) examined performance in the 6-minute walk, stair ascent, stair descent, and timed up-and-go tests for 109 community-dwelling adults aged 60 years and over. Using magnetic resonance imaging (MRI) to determine thigh muscle composition, the investigators observed that IMAT explained between 8% and 15% of the variance for each of the 4 mobility variables, whereas muscle mass explained only 5% of the variance in the 6-minute walk alone. These studies indicate that IMAT is a significant independent predictor of muscle function and physical performance in older adults. There are a number of links between vitamin D and adipose tissue. Low vitamin D in humans is associated with obesity, the metabolic syndrome, and type 2 diabetes mellitus (7). The VDR is highly expressed in adipocytes, and vitamin D can be stored in fat tissues. Additionally, it is possible that 1,25OH2D3 inhibits adipogenesis through interactions with peroxisome proliferator-activated receptor γ in rodent models, although there is conflicting evidence suggesting that 1,25OH2D3 may stimulate adipogenesis in human adipocytes (8). These disparities may reflect differences in cell culture models and/or species differences and require further investigation in light of a recent study, the first to examine the effects of 1,25OH2D3 in transdifferentiation of muscle cells into adipose cells. The investigators reported that low physiological concentrations of 1,25OH2D3 induce myoblasts to transdifferentiate into an adipogenic lineage, whereas high concentrations block adipogenic transdifferentiation, in the murine C2C12 muscle cell (9). Thus, it is plausible that higher circulating levels of vitamin D inhibit the deposition of IMAT, potentially through reducing the transdifferentiation of myogenic precursor cells into adipocytes, resulting in greater maintenance of skeletal muscle quality and subsequent better muscle function. There are few data describing associations between vitamin D and IMAT in humans. Gilsanz et al (10) investigated serum 25OHD and skeletal muscle composition at the midthigh using CT in 90 young women and observed a strong negative relationship between vitamin D and muscle attenuation, which was independent of sc and visceral fat levels. In 20 older men and women, MRI-derived muscular fatty degeneration of the thigh was significantly negatively correlated with 25OHD levels and performance in gait and balance tests (11). Higher circulating levels of vitamin D may therefore have beneficial effects for skeletal muscle composition and function through an association with reduced IMAT deposition in humans. In summary, the mechanisms by which higher levels of vitamin D prevent age-related declines in skeletal muscle function and incident falls in older populations are presently unclear. Research is required to confirm the presence and role of the VDR in skeletal muscle in vivo and the relationship of vitamin D with adipogenesis to clarify independent effects of vitamin D on skeletal muscle and IMAT deposition. The increasing availability and affordability of imaging techniques such as CT and MRI provide a useful noninvasive technique for researchers to quantify IMAT, although muscle biopsy may be the most precise method of determining skeletal muscle fat infiltration. Investigations into intra-myocellular lipid content using muscle biopsy are of interest because excess accumulation of intra-myocellular lipid content is implicated in insulin resistance (12). Low vitamin D levels are likewise associated with insulin resistance, diabetes, and cardiovascular disease (3), which may independently contribute to declines in physical performance. Additionally, observational studies and clinical trials assessing other potential causes of muscle composition changes, such as physical activity and dietary nutrient intake, are required. Confirmation of this important association would enhance our understanding of the effects of vitamin D on muscle function, resulting in improved efficacy of clinical and public health recommendations for healthy aging. Disclosure Summary: The authors have nothing to disclose. computed tomography 1,25-dihydroxyvitamin D3 25-hydroxyvitamin D intra- and intermuscular adipose tissue magnetic resonance imaging vitamin D receptor.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: